Ractigen's RAG-01 Shows Promising Early Complete Responses in Phase I NMIBC Trial, Data Presented at EAU 2025
NANTONG, China and MELBOURNE, Australia, March 24, 2025 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage biopharmaceutical company pioneering small activating RNA (saRNA) therapeutics, today announced the presentation of positive preliminary...
NYSE CONTENT ADVISORY: The NYSE on the ground at HumanX's inaugural AI conference
NEW YORK, March 24, 2025 /PRNewswire/ -- As a leading global exchange, the NYSE is committed to empowering our diverse communities, wherever they may be. Engaging with our listed companies and emerging startups at key industry events is an...
ALUMINIUM CHINA 2025: Join Us in Celebrating 20 Years of Innovation and Global Collaboration
SHANGHAI, March 24, 2025 /PRNewswire/ -- ALUMINIUM CHINA 2025 is set to mark a monumental milestone — its 20th anniversary — welcoming global industry professionals to an enhanced, reimagined edition of Asia's premier trade fair for the aluminium...
Krazy Degen: Discovering the Next On-Chain Gem with KuCoin
VICTORIA, Seychelles, March 24, 2025 /PRNewswire/ -- KuCoin, a global leader in the cryptocurrency exchange market, proudly announces the launch of its innovative new platform, 'Krazy Degen', which serves as an all-encompassing information hub...
Europe Becomes a New Strategic Hub for ChangAn Automobile's "Vast Ocean Plan" as Global Growth Accelerates
Review of the Globalization Journey of the Vast Ocean Plan MUNICH, March 24, 2025 /PRNewswire/ -- ChangAn Automobile ("ChangAn" or "the Company"), an intelligent low-carbon mobility technology company, launched its CHANG-AN, DEEPAL, and AVATR brands...
Money Talks: Study Reveals Inflation and Tariffs Are Reshaping American Shopping
LOS ANGELES, March 24, 2025 /PRNewswire/ -- Personal finances are top of mind for American shoppers in 2025, according to recent research conducted by The Harris Poll on behalf of global fashion and lifestyle online retailer SHEIN. The new study,...
SineuGene Therapeutics Announces FDA IND Clearance for SNUG01, a First-in-Class TRIM72-Targeted Gene Therapy for ALS
BEIJING, March 24, 2025 /PRNewswire/ -- SineuGene Therapeutics Co., Ltd. ("SineuGene"), a clinical-stage biotech company pioneering innovative therapies for neurological disorders, today announced that the U.S. Food and Drug Administration (FDA) has...
TROOPS, Inc. (Nasdaq: TROO) Explores Acquisition of Hong Kong Insurance Brokerage and Nears Agreement to Acquire Bestfaith International Technology Limited
Strategic Moves to Expand Footprint in Hong Kong's Real Estate and Insurance Sectors HONG KONG, March 24, 2025 /PRNewswire/ -- TROOPS, Inc. (Nasdaq: TROO) (the "Company" or "TROOPS") today announced two strategic initiatives to accelerate its growth...